Machine Perfusion in High vs Low/Mid-volume Liver Transplant Centers: a Multicentre Survey
NCT ID: NCT05662969
Last Updated: 2022-12-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
67 participants
OBSERVATIONAL
2021-12-31
2022-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Methods: An Online 22-item survey on the use of machine perfusion for liver transplantation outside of clinical trials, was distributed to worldwide LT centres representatives. Variables of interest included MP logistics, MP technicalities, MP results, post-MP LT results. Responding centres were grouped into high volume centre (HVCs)(defined as \>60 LTs per year in 2019) and L/MVCs. Results from HVCs vs L/MVCs were compared.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Low/mid-volume liver transplant centres
MACHINE PERFUSION
Different outcomes of MP use in low/mid-volume and high-volume LT centres
High-volume liver transplant centres
MACHINE PERFUSION
Different outcomes of MP use in low/mid-volume and high-volume LT centres
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MACHINE PERFUSION
Different outcomes of MP use in low/mid-volume and high-volume LT centres
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* LT centres which perform LT before pandemic time (before 2019 included)
* LT centres which perform LT from cadaveric donors and living donors
Exclusion Criteria
* LT centres that use MP but on clinical trials
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Roberta Angelico
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Roberta Angelico
Principal investigator, Professor, MD, PhD, FEBS
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Roberta Angelico
Rome, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MPLTPTV1
Identifier Type: -
Identifier Source: org_study_id